Tuesday, June 9, 2015

Spotlight Innovation Inc. acquired a majority ownership in Memcine Pharmaceuticals Inc., a company based at the University of Iowa Research Park. Memcine Pharmaceuticals is developing a technology that uses the body's natural targeting system to deliver vaccine components to immune cells and stimulate a response. Read more online.